Sakar Healthcare Share price target & analyst calls

₹904.8-18.40 (-1.99%)

As of 21 Oct 2026

Only one active 1-year target

The long-term call is BUY

₹1,31044.8% above today's price

Sakar Healthcare has one active 1-year share price target: ₹1,310 from ICICI Securities (17 Sept 2026). One target is a single view, not a consensus.

1 BUY · 0 SELL, all horizons

with an active 1Y target

N/A

2 of 10 closed calls needed

all horizons, open and closed

Watch SAKAR for new buy/sell callsGet alerts See 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

What’s happening with the stock

1 upcoming · Technicals

Upcoming

Q2 FY27 results scheduled — board meets 23 Oct 2026

Earnings calendar

23 Oct 2026

Not investment advice.

Technical indicators

26.3

Oversold

−10.5% (₹1,011.38)

Bearish

+24.6% (₹725.93)

Bullish

23.9% below high · 157.4% above low

Context

203K · 1.4×

Above avg

Technical indicators are computed from exchange prices. Not investment advice.

All tips (3)

BUYTarget₹1,310

ISbyICICI Securities+44.8% to target

1 Year* · 11 mo left · 17 Sept 2026 · entry ₹1,129.55 · via Institutional / Brokerage ResearchP&L -19.9%

BUYTarget₹605

ISbyICICI SecuritiesTarget hit

1 Year* · 19 Feb 2026 · entry ₹461.8 · via Institutional / Brokerage Researchexit ₹605

BUYTarget₹990

SJbySandeep Jain, TradeswiftExpired

1–2 Weeks* · 28 Jul 2026 · entry ₹846.9 · via Zee Business (Live)exit ₹910

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks